Release Summary

Newron announced the initiation of the Sarizotan Treatment of Apneas in Rett Syndrome (STARS) study, a potentially pivotal clinical study to evaluate sarizotan to treat apneas in Rett syndrome

Newron Pharmaceuticals S.p.A.